Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients.

[1]  Lutz Heinemann,et al.  Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors , 2008, Diabetes Care.

[2]  B. Braun,et al.  Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial. , 2008, Diabetes research and clinical practice.

[3]  R. Gerard Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. , 2008 .

[4]  H. Lapinski,et al.  Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom? , 2007, Diabetes & metabolism.

[5]  Bruce Buckingham,et al.  Real-time continuous glucose monitoring , 2007, Current opinion in endocrinology, diabetes, and obesity.

[6]  T. Rönnemaa,et al.  Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. , 2007, Diabetes research and clinical practice.

[7]  A. Farmer,et al.  Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial , 2007, BMJ : British Medical Journal.

[8]  T. Kubiak,et al.  Microdialysis-based 48-hour continuous glucose monitoring with GlucoDay: clinical performance and patients' acceptance. , 2006, Diabetes technology & therapeutics.

[9]  K. Dear,et al.  Continuous Glucose Monitoring–Guided Insulin Adjustment in Children and Adolescents on Near-Physiological Insulin Regimens , 2006, Diabetes Care.

[10]  P. Rossetti,et al.  Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. , 2006, Diabetes technology & therapeutics.

[11]  H. Guess,et al.  Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single‐blind, randomized, controlled trial , 2006, Pediatric diabetes.

[12]  Jean-Paul Cristol,et al.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.

[13]  H Hanaire-Broutin,et al.  Value and limitations of the Continuous Glucose Monitoring System in the management of type 1 diabetes. , 2006, Diabetes & metabolism.

[14]  O. Kordonouri,et al.  Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[15]  J Hans DeVries,et al.  Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients. , 2005, Diabetes care.

[16]  L. Bouter,et al.  Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. , 2005, Diabetes care.

[17]  Kathryn Tan,et al.  Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004)* , 2005, Current medical research and opinion.

[18]  Claresa Levetan,et al.  Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. , 2004, Mayo Clinic proceedings.

[19]  L. V. Van Gaal,et al.  Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device , 2004, Diabetes/metabolism research and reviews.

[20]  J. Silverstein,et al.  Predictors of control of diabetes: monitoring may be the key. , 2004, The Journal of pediatrics.

[21]  P. Schaepelynck-Belicar,et al.  Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). , 2003, Diabetes & metabolism.

[22]  F Valgimigli,et al.  A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 2). , 2003, Biosensors & bioelectronics.

[23]  Johnny Ludvigsson,et al.  Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. , 2003, Pediatrics.

[24]  A. Novials,et al.  The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. , 2003, Diabetes care.

[25]  R. Schiaffini,et al.  The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk , 2002, Diabetes/metabolism research and reviews.

[26]  Alberto Maran,et al.  Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. , 2002, Diabetes care.

[27]  W. Tamborlane,et al.  Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. , 2001, Diabetes care.

[28]  Jennifer Y. Liu,et al.  Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. , 2001, The American journal of medicine.

[29]  H. Chase,et al.  Continuous subcutaneous glucose monitoring in children with type 1 diabetes. , 2001, Pediatrics.

[30]  B P Kovatchev,et al.  Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. , 1998, Diabetes care.

[31]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[32]  M. Engelgau,et al.  Population-Based Assessment of the Level of Care Among Adults With Diabetes in the U.S , 1998, Diabetes Care.

[33]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[34]  W. F. Taylor,et al.  Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability , 1970, Diabetes.

[35]  J. Schlichtkrull,et al.  [M-VALUE, AN INDEX FOR BLOOD SUGAR CONTROL IN DIABETICS]. , 1964, Ugeskrift for laeger.

[36]  L. Monnier,et al.  Contributions of fasting and postprandial glucose to hemoglobin A1c. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[37]  A. Ceriello Postprandial hyperglycemia and diabetes complications: is it time to treat? , 2005, Diabetes.

[38]  M. Hanefeld,et al.  Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. , 2004, European heart journal.